Lenka Markova

16PUBLICATIONS
34CO-AUTHORS
Transition metal chemistryCancer therapy (excl. chemotherapy and radiation therapy)Metal organic frameworksPharmaceutical delivery technologiesOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 16, 2026
Novel 2-(2'-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance.

Antonio Linero-Artiaga, Marie Svitelova, Vojtěch Novohradský

|Nov 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová

|Dec 02, 2024
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.

Alicia Marco, Jana Kasparkova, Delia Bautista

|May 31, 2024
Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.

Lenka Markova, Moumita Maji, Hana Kostrhunova

|Dec 23, 2023
Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis.

Jana Kasparkova, Alba Hernández-García, Hana Kostrhunova

|Aug 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji

Pageof 3

Frequent Collaborators

15 joint publications

Viktor Brabec

12 joint publications

Jana Kasparkova

12 joint publications

Vojtech Novohradsky

7 joint publications

Hana Kostrhunova